Study ID: RA-TL011-101 | 2009-015702-18
Study Title
- TL011 in Severe, Active Rheumatoid Arthritis Patients
Teva Identifier
- RA-TL011-101 | 2009-015702-18
ClinicalTrials.gov Identifier
- NCT01123070
Study Status
- Completed
Trial Condition(s)
- Rheumatoid Arthritis
Interventions
- Biological: TL011, anti CD20, for the treatment of rheumatoid arthritis | Biological: MabThera infusions
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 80 Years
Trial Duration
- 02/01/2010 - 05/01/2012
Phase
- Phase 1/2
Study Type
Interventional
